Background: Optimal timing of arteriovenous fistula (AVF) surgery in chronic kidney disease (CKD) is uncertain. Methods: A single-centre retrospective study of pre-dialysis CKD patients having first AVF surgery. Results: The median estimated glomerular filtration rate (eGFR) at the time of AVF surgery in 100 patients was 15 ml/min/1.73 m2, with patients classified as having an early AVF if eGFR was >15 ml/min/1.73 m2 (n = 46) or a late AVF if eGFR was ≤15 ml/min/1.73 m2 (n = 54). In the eGFR ≤15 group, 81% of patients started haemodialysis (HD), compared with 63% of the eGFR >15 patients (p = 0.04). The median time to starting HD was 30.3 months in the eGFR >15 group compared to 10.7 months for the eGFR ≤15 group (log rank p = 0.018). There were no differences in the requirements for a dialysis catheter (eGFR >15 24% vs. eGFR ≤15 11%, p = 0.20) or additional access procedures between the two groups. Conclusions: AVF surgery with an eGFR >15 ml/min/1.73 m2 was associated with a higher risk of AVF non-use and a more prolonged time to the need for HD.

Ravani P, Palmer SC, Oliver MJ, Quinn RR, MacRae JM, Tai DJ, Pannu NI, Thomas C, Hemmelgarn BR, Craig JC, Manns B, Tonelli M, Strippoli GF, James MT: Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol 2013;24:465-473.
Xue JL, Dahl D, Ebben JP, Collins AJ: The association of initial hemodialysis access type with mortality outcomes in elderly Medicare ESRD patients. Am J Kidney Dis 2003;42:1013-1019.
Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG: Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol 2004;15:477-486.
Bradbury BD, Fissell RB, Albert JM, Anthony MS, Critchlow CW, Pisoni RL, Port FK, Gillespie BW: Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol 2007;2:89-99.
Moist LM, Trpeski L, Na Y, Lok CE: Increased hemodialysis catheter use in Canada and associated mortality risk: data from the Canadian Organ Replacement Registry 2001-2004. Clin J Am Soc Nephrol 2008;3:1726-1732.
Vascular Access Work G: Clinical practice guidelines for vascular access. Am J Kidney Dis 2006;48(suppl 1):S248-S273.
Sidawy AN, Spergel LM, Besarab A, Allon M, Jennings WC, Padberg FT Jr, Murad MH, Montori VM, O'Hare AM, Calligaro KD, Macsata RA, Lumsden AB, Ascher E, Society for Vascular S: The Society for Vascular Surgery: clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access. J Vasc Surg 2008;48(5 suppl):2S-25S.
Jindal K, Chan CT, Deziel C, Hirsch D, Soroka SD, Tonelli M, Culleton BF, Canadian Society of Nephrology Committee for Clinical Practice G: Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology. J Am Soc Nephrol 2006;17(3 suppl 1):S1-S27.
Hoggard J, Saad T, Schon D, Vesely TM, Royer T, American Society of D, Interventional Nephrology CPC, Association for Vascular A: Guidelines for venous access in patients with chronic kidney disease. A Position Statement from the American Society of Diagnostic and Interventional Nephrology, Clinical Practice Committee and the Association for Vascular Access. Semin Dial 2008;21:186-191.
Tordoir J, Canaud B, Haage P, Konner K, Basci A, Fouque D, Kooman J, Martin-Malo A, Pedrini L, Pizzarelli F, Tattersall J, Vennegoor M, Wanner C, ter Wee P, Vanholder R: EBPG on Vascular Access. Nephrol Dial Transplant 2007;22(suppl 2):ii88-ii117.
Huijbregts HJ, Bots ML, Wittens CH, Schrama YC, Moll FL, Blankestijn PJ, group Cs: Hemodialysis arteriovenous fistula patency revisited: results of a prospective, multicenter initiative. Clin J Am Soc Nephrol 2008;3:714-719.
O'Hare AM, Bertenthal D, Walter LC, Garg AX, Covinsky K, Kaufman JS, Rodriguez RA, Allon M: When to refer patients with chronic kidney disease for vascular access surgery: should age be a consideration? Kidney Int 2007;71:555-561.
Weber CL, Djurdjev O, Levin A, Kiaii M: Outcomes of vascular access creation prior to dialysis: building the case for early referral. ASAIO J 2009;55:355-360.
Schinstock CA, Albright RC, Williams AW, Dillon JJ, Bergstralh EJ, Jenson BM, McCarthy JT, Nath KA: Outcomes of arteriovenous fistula creation after the Fistula First Initiative. Clin J Am Soc Nephrol 2011;6:1996-2002.
Oliver MJ, Quinn RR, Garg AX, Kim SJ, Wald R, Paterson JM: Likelihood of starting dialysis after incident fistula creation. Clin J Am Soc Nephrol 2012;7:466-471.
Blake PG, Quinn RR, Oliver MJ: The risks of vascular access. Kidney Int 2012;82:623-625.
Mathew TH, Australasian Creatinine Consensus Working G: Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: a position statement. Med J Aust 2005;183:138-141.
Centers for M, Medicaid S, Kinney R: 2005 Annual Report: ESRD Clinical Performance Measures Project. Am J Kidney Dis 2006;48(4 suppl 2):S1-S106.
Lopez-Vargas PA, Craig JC, Gallagher MP, Walker RG, Snelling PL, Pedagogos E, Gray NA, Divi MD, Gillies AH, Suranyi MG, Thein H, McDonald SP, Russell C, Polkinghorne KR: Barriers to timely arteriovenous fistula creation: a study of providers and patients. Am J Kidney Dis 2011;57:873-882.
FistulaFirst. Fistula First Change Concepts.
Fluck R, Kumwenda M: Renal Association Clinical Practice Guideline on vascular access for haemodialysis. Nephron Clin Pract 2011;118(suppl 1):c225-c240.
Allon M, Bailey R, Ballard R, Deierhoi MH, Hamrick K, Oser R, Rhynes VK, Robbin ML, Saddekni S, Zeigler ST: A multidisciplinary approach to hemodialysis access: prospective evaluation. Kidney Int 1998;53:473-479.
Dwyer A, Shelton P, Brier M, Aronoff G: A vascular access coordinator improves the prevalent fistula rate. Semin Dial 2012;25:239-243.
Voormolen EH, Jahrome AK, Bartels LW, Moll FL, Mali WP, Blankestijn PJ: Nonmaturation of arm arteriovenous fistulas for hemodialysis access: A systematic review of risk factors and results of early treatment. J Vasc Surg 2009;49:1325-1336.
MacRae JM, Pandeya S, Humen DP, Krivitski N, Lindsay RM: Arteriovenous fistula-associated high-output cardiac failure: a review of mechanisms. Am J Kidney Dis 2004;43:e17-e22.
Nakhoul F, Yigla M, Gilman R, Reisner SA, Abassi Z: The pathogenesis of pulmonary hypertension in haemodialysis patients via arterio-venous access. Nephrol Dial Transplant 2005;20:1686-1692.
Beathard GA, Spergel LM: Hand ischemia associated with dialysis vascular access: an individualized access flow-based approach to therapy. Semin Dial 2013;26:287-314.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.